Retatrutide (Reta)
-
Detail
Retatrutide (Reta) Compound Overview
Retatrutide (Reta) is a synthetic research peptide described in published literature as acting across GIP, GLP-1, and glucagon receptor systems. This page identifies the material as Retatrutide (Reta), with amino acid count 39; synonyms LY3437943; LY-3437943. The Retatrutide (Reta) identifiers distinguish this catalogue entry from similarly named compounds, fragments, modified analogues, and multi-component formulations.
A Three-Receptor Research Profile
The research record for Retatrutide (Reta) is organized around GIPR, GLP-1R, and GCGR pharmacology, multi-receptor ligand profiling, signal-response analysis, and analytical peptide characterization. For Retatrutide (Reta), those subjects define the literature and analytical context of this specific research peptide; they do not establish a clinical indication, administration route, or expected outcome.
Available Retatrutide (Reta) Specifications
The live selector currently lists 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg, 100mg for Retatrutide (Reta), supplied as 10 Vials. Each selectable Retatrutide (Reta) specification retains its own SKU, displayed price, inventory record, and matched image, so the chosen option can be checked without relying on a generic dose range.
Retatrutide (Reta) Identity & Composition
Compound / Blend Retatrutide (Reta) Available Specifications 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg, 100mg Pack Format 10 Vials CAS Number 2381089-83-2 Amino Acid Count 39 Sequence 39-residue peptide. Structural modifications and residue numbering follow the cited primary publication; PubChem currently lists retatrutide as a reference record without a discrete compound structure. Synonyms LY3437943; LY-3437943 Physical Form Lyophilized powder Record boundary: Molecular identifiers describe the named Retatrutide (Reta) form; lot-specific analytical results remain in the matched COA record.
How to Read the Retatrutide (Reta) COA
NOVABIO currently displays 4 matched certificate records for Retatrutide (Reta), covering 30 mg, 10 mg. The newest listed record is batch NV-RT30-0725, tested Aug 18, 2026, with reported purity 99.80% and net content 34.25 mg. For Retatrutide (Reta), match the selected specification and batch number to the displayed certificate; results from one lot are not generalized to every variant.
Research Use Notice
This material is supplied for controlled laboratory and research use only. It is not intended for human or animal consumption, diagnosis, treatment, administration, or therapeutic use. Buyers should review the selected specification and its matched documentation before ordering.
Related Products
Compare other listings in the GLP-1 Peptides collection.
Related Research Guides
-
Customer ReviewsNo comments
USD



